Ardevora Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-247,683
Closed -$65.6M 148
2021
Q4
$65.6M Sell
247,683
-23,400
-9% -$6.3M 0.7% 103
2021
Q3
$78.3M Sell
271,083
-11,500
-4% -$2.95M 0.99% 6
2021
Q2
$56.4M Buy
282,583
+24,650
+10% +$4.78M 0.71% 108
2021
Q1
$50.1M Sell
257,933
-32,377
-11% -$6.64M 0.75% 93
2020
Q4
$55.6M Buy
+290,310
New +$52.8M 0.86% 73
2020
Q2
Sell
-473,433
Closed -$45.7M 125
2020
Q1
$45.7M Buy
+473,433
New +$45.7M 1.21% 10
2019
Q3
Sell
-552,877
Closed -$47.5M 114
2019
Q2
$47.5M Sell
552,877
-42,100
-7% -$2.87M 1.16% 3
2019
Q1
$35.2M Sell
594,977
-17,100
-3% -$983K 0.92% 57
2018
Q4
$32.3M Buy
612,077
+505,020
+472% +$29.6M 0.97% 59
2018
Q3
$5.94M Buy
+107,057
New +$5.52M 0.17% 114

Other funds holding RGEN

Ardevora Asset Management's RGEN Position: Q1 2022 in Review

Ardevora Asset Management sold out of Repligen (RGEN) in Q1 2022, closing a stake of 247,683 shares — an estimated $65.6M sold.

Ardevora Asset Management first reported a position in RGEN in Q3 2018 and held it in 10 quarters. The position peaked at $78.3M in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Ardevora Asset Management reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Ardevora Asset Management sold 247,683 Repligen shares in Q1 2022, an estimated $65.6M.
  • Ardevora Asset Management first reported a position in Repligen in Q3 2018 and held it in 10 quarters.
  • Ardevora Asset Management's Repligen position peaked at $78.3M in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Ardevora Asset Management's 13F filing for Q1 2022, filed 28 Apr 2022.